118 related articles for article (PubMed ID: 38240306)
1.
Giri PS; Bhimani R; Laddha NC; Dwivedi M
Nucleosides Nucleotides Nucleic Acids; 2024 Jan; ():1-15. PubMed ID: 38240306
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of nuclear factor of activated T cells' 3'UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population.
Giri P; Bhimani R; Patil S; Dwivedi M
Gene; 2023 Sep; 880():147629. PubMed ID: 37429370
[TBL] [Abstract][Full Text] [Related]
3. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
Giri PS; Patel S; Begum R; Dwivedi M
Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
[TBL] [Abstract][Full Text] [Related]
4. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
[TBL] [Abstract][Full Text] [Related]
5. Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo.
Giri PS; Patel SS; Dwivedi M
Hum Immunol; 2024 Jan; 85(1):110737. PubMed ID: 38057201
[TBL] [Abstract][Full Text] [Related]
6. Decreased
Giri PS; Bharti AH; Dwivedi M
J Immunol Res; 2022; 2022():3426717. PubMed ID: 36157881
[TBL] [Abstract][Full Text] [Related]
7. The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.
Wang P; Li Y; Nie H; Zhang X; Shao Q; Hou X; Xu W; Hong W; Xu A
J Dermatol Sci; 2016 Oct; 84(1):40-49. PubMed ID: 27470284
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between autophagy of melanocytes in patients with vitiligo and clinical types].
Nie HQ; Wang P; Zhang XY; Ding C; Liu J; Xu AE
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2064-9. PubMed ID: 27468618
[TBL] [Abstract][Full Text] [Related]
9. Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism.
Attili VR; Attili SK
Indian J Dermatol; 2013 Nov; 58(6):433-8. PubMed ID: 24249893
[TBL] [Abstract][Full Text] [Related]
10. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma.
Spritz RA
Genome Med; 2010 Oct; 2(10):78. PubMed ID: 20959028
[TBL] [Abstract][Full Text] [Related]
11. Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population.
Singh M; Mansuri MS; Jadeja SD; Marfatia YS; Begum R
Indian J Dermatol Venereol Leprol; 2018; 84(3):285-291. PubMed ID: 29620037
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in the genetics of generalized vitiligo.
Spritz RA
J Genet Genomics; 2011 Jul; 38(7):271-8. PubMed ID: 21777851
[TBL] [Abstract][Full Text] [Related]
13. Does autoimmune vitiligo protect against COVID-19 disease?
Post NF; Luiten RM; Wolkerstorfer A; Bekkenk MW; Böhm M
Exp Dermatol; 2021 Sep; 30(9):1254-1257. PubMed ID: 34081788
[TBL] [Abstract][Full Text] [Related]
14. Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
Giri PS; Bharti AH; Begum R; Dwivedi M
Immunology; 2022 Nov; 167(3):314-327. PubMed ID: 35754117
[TBL] [Abstract][Full Text] [Related]
15. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.
Spritz RA
J Invest Dermatol; 2012 Feb; 132(2):268-73. PubMed ID: 21993561
[TBL] [Abstract][Full Text] [Related]
16. Implication of regulatory T cells' telomere shortening in pathogenesis of generalized vitiligo.
Giri P; Thakor F; Dwivedi M
Hum Immunol; 2024 May; ():110812. PubMed ID: 38755031
[TBL] [Abstract][Full Text] [Related]
17. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.
Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R
Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783
[TBL] [Abstract][Full Text] [Related]
19. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
Giri PS; Bharti AH; Kode J; Begum R; Dwivedi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
[TBL] [Abstract][Full Text] [Related]
20. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.
Jadeja SD; Mansuri MS; Singh M; Dwivedi M; Laddha NC; Begum R
PLoS One; 2017; 12(7):e0180958. PubMed ID: 28700671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
